Search
for
Sort by
Research 631–660 of 1000+
- NIGELLA SATIVA L.: AN OVERVIEW
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Arabidopsis retromer subunit AtVPS29 is involved in SLY1-mediated gibberellin signaling
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Dermatolojik Problemler ve COVID-19
- Alopecia Areata: Current Review
- Complications associated with oncological therapy - how to minimize?
- Live Imaging of the Skin Immune Responses
- Follikelhormone
- The problems of alopecia in young women
- Hair Changes due to Drugs
- Influence of donor sources and culture media on the histo-morphological quality of human artificial skin models
- Dermatological history and examination
- Azathioprine: A therapy to be considered in alopecia universalis
- Diphencyprone in the treatment of Satoyoshi syndrome
- Undifferentiated connective tissue disease presenting with vascular pattern of renal amyloidosis with carpel tunnel syndrome: A case report
- Skin Disorders
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- British Society for Dermatopathology: Summaries of Papers
- Psoriasis
- Abstracts from the Symposium on the Pathophysiology of Hair Growth Organized by the Institute of Dermatology at the Royal Society of Medicine, 29 October 1987
- Differential Diagnosis of Male and Female Pattern Hair Loss
- Is COVID-19 Gender-sensitive?
- Sex steroid synthesis in human skin in situ: The roles of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- The role of versican in the skin ECM and its interaction with hyaluronic acid
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Farmácia São Lázaro - Porto e nos Serviços Farmacêuticos do Hospital Privado de Vila Real (Grupo Trofa Saúde) - Vila Real
- Farmácia Azevedo Carvalho, Cabeceiras de Bastos